A Researcher’s Hope For Sequencing: Rare Genetic Variants Yield New Drugs
Executive Summary
Columbia University Professor Wendy Chung’s work on identifying the causative mutations underlying ultra-rare diseases such as hereditary pulmonary hypertension puts a real-world perspective on pharma’s increasing interest in genomic analysis as a tool for drug discovery.